A randomized controlled trial on levidex, a digital health application, has shown clinically significant improvement in disease-specific quality of life for people with multiple sclerosis. The study found that levidex improved MS-specific quality of life, depressive symptoms, and social functioning in participants.
SourceGAIA (Germany)·JournalMultiple Sclerosis Journal - Experimental Translational and Clinical·TypeRandomized controlled/clinical trial·DateAug 13, 2026 A secondary analysis of the digital insomnia therapy somnovia identifies reducing hyperarousal as its primary mechanism of action for treating chronic insomnia. This process is linked to numerous other mental health conditions, suggesting positive effects beyond just sleep disorders.
A randomized controlled trial demonstrates a significant and clinically relevant reduction in ADHD symptoms in adults using attexis, a digital intervention based on cognitive behavioral therapy. The results show improvements in work and social functioning, self-esteem, and quality of life, as well as a reduction in depressive symptoms.
A randomized controlled trial demonstrates the effectiveness of mylovia, a digital therapy for female sexual dysfunction, showing significant improvements in sexual function and related symptoms. The study suggests that mylovia can provide women with a self-guided intervention to overcome sexual dysfunction and experience deeper pleasure.